The Journal of Antibiotics The Journal of Antibiotics seeks to promote research on antibiotics and related types of biologically active substances and publishes Articles, Review Articles, Brief Communication, Correspondence and other specially commissioned reports. The Journal of Antibiotics accepts papers on biochemical, chemical, microbiological and pharmacological studies. However, studies regarding human therapy do not fall under the journal’s scope. Contributions regarding recently discovered antibiotics and biologically active microbial products are particularly encouraged. Topics of particular interest within the journal's scope include, but are not limited to, those listed below: - Discovery of new antibiotics and related types of biologically active substances - Production, isolation, characterization, structural elucidation, chemical synthesis and derivatization, biological activities, mechanisms of action, and structure-activity relationships of antibiotics and related types of biologically active substances - Biosynthesis, bioconversion, taxonomy and genetic studies on producing microorganisms, as well as improvement of production of antibiotics and related types of biologically active substances - Novel physical, chemical, biochemical, microbiological or pharmacological methods for detection, assay, determination, structural elucidation and evaluation of antibiotics and related types of biologically active substances - Newly found properties, mechanisms of action and resistance-development of antibiotics and related types of biologically active substances http://feeds.nature.com/ja/rss/current Nature Publishing Group en © 2024 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. The Journal of Antibiotics © 2024 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. permissions@nature.com The Journal of Antibiotics https://www.nature.com/uploads/product/ja/rss.gif http://feeds.nature.com/ja/rss/current <![CDATA[New polycyclic tetramate macrolactams with antimycobacterial activity produced by marine-derived <i>Streptomyces</i> sp. KKMA-0239]]> https://www.nature.com/articles/s41429-024-00710-w The Journal of Antibiotics, Published online: 26 March 2024; doi:10.1038/s41429-024-00710-w

New polycyclic tetramate macrolactams with antimycobacterial activity produced by marine-derived Streptomyces sp. KKMA-0239]]>
Streptomyces sp. KKMA-0239]]> Satoru ShigenoMiyu KadowakiKenichiro NagaiKanji HosodaTakeshi TeraharaTomoyasu NishimuraNaoki HasegawaHiroshi TomodaTaichi Ohshiro doi:10.1038/s41429-024-00710-w The Journal of Antibiotics, Published online: 2024-03-26; | doi:10.1038/s41429-024-00710-w 2024-03-26 The Journal of Antibiotics 10.1038/s41429-024-00710-w https://www.nature.com/articles/s41429-024-00710-w
<![CDATA[<i>Actinomycetospora termitidis</i> sp. nov., an insect-derived actinomycete isolated from termite (<i>Odontotermes formosanus</i>)]]> https://www.nature.com/articles/s41429-024-00712-8 The Journal of Antibiotics, Published online: 25 March 2024; doi:10.1038/s41429-024-00712-8

Actinomycetospora termitidis sp. nov., an insect-derived actinomycete isolated from termite (Odontotermes formosanus)]]>
Actinomycetospora termitidis sp. nov., an insect-derived actinomycete isolated from termite (Odontotermes formosanus)]]> Khomsan SupongNantawan NiemhomChanwit SuriyachadkunWongsakorn PhongsopitanunSomboon TanasupawatPattama Pittayakhajonwut doi:10.1038/s41429-024-00712-8 The Journal of Antibiotics, Published online: 2024-03-25; | doi:10.1038/s41429-024-00712-8 2024-03-25 The Journal of Antibiotics 10.1038/s41429-024-00712-8 https://www.nature.com/articles/s41429-024-00712-8
<![CDATA[Tumescenamide C, a cyclic lipodepsipeptide from <i>Streptomyces</i> sp. KUSC_F05, exerts antimicrobial activity against the scab-forming actinomycete <i>Streptomyces scabiei</i>]]> https://www.nature.com/articles/s41429-024-00716-4 The Journal of Antibiotics, Published online: 25 March 2024; doi:10.1038/s41429-024-00716-4

Tumescenamide C, a cyclic lipodepsipeptide from Streptomyces sp. KUSC_F05, exerts antimicrobial activity against the scab-forming actinomycete Streptomyces scabiei]]>
Streptomyces sp. KUSC_F05, exerts antimicrobial activity against the scab-forming actinomycete Streptomyces scabiei]]> Kensuke KanekoMarika MiedaYulu JiangNobuaki TakahashiHideaki Kakeya doi:10.1038/s41429-024-00716-4 The Journal of Antibiotics, Published online: 2024-03-25; | doi:10.1038/s41429-024-00716-4 2024-03-25 The Journal of Antibiotics 10.1038/s41429-024-00716-4 https://www.nature.com/articles/s41429-024-00716-4
<![CDATA[Okichromanone, a new antiviral chromanone from a marine-derived <i>Microbispora</i>]]> https://www.nature.com/articles/s41429-024-00718-2 The Journal of Antibiotics, Published online: 22 March 2024; doi:10.1038/s41429-024-00718-2

Okichromanone, a new antiviral chromanone from a marine-derived Microbispora]]>
Microbispora]]> Marwa ElsbaeyTakahiro JomoriJunichi TanakaNaoya OkuYasuhiro Igarashi doi:10.1038/s41429-024-00718-2 The Journal of Antibiotics, Published online: 2024-03-22; | doi:10.1038/s41429-024-00718-2 2024-03-22 The Journal of Antibiotics 10.1038/s41429-024-00718-2 https://www.nature.com/articles/s41429-024-00718-2
<![CDATA[Three new phthalide derivatives from culture broth of <i>Dentipellis fragilis</i> and their cytotoxic activities]]> https://www.nature.com/articles/s41429-024-00720-8 The Journal of Antibiotics, Published online: 22 March 2024; doi:10.1038/s41429-024-00720-8

Three new phthalide derivatives from culture broth of Dentipellis fragilis and their cytotoxic activities]]>
Dentipellis fragilis and their cytotoxic activities]]> Dae-Won KiDae-Cheol ChoiYeong-Seon WonSeung-Jae LeeYoung-Hee KimIn-Kyoung LeeBong-Sik Yun doi:10.1038/s41429-024-00720-8 The Journal of Antibiotics, Published online: 2024-03-22; | doi:10.1038/s41429-024-00720-8 2024-03-22 The Journal of Antibiotics 10.1038/s41429-024-00720-8 https://www.nature.com/articles/s41429-024-00720-8
<![CDATA[Uncovering the potentiality of quinazoline derivatives against <i>Pseudomonas aeruginosa</i> with antimicrobial synergy and SAR analysis]]> https://www.nature.com/articles/s41429-024-00717-3 The Journal of Antibiotics, Published online: 21 March 2024; doi:10.1038/s41429-024-00717-3

Uncovering the potentiality of quinazoline derivatives against Pseudomonas aeruginosa with antimicrobial synergy and SAR analysis]]>
Pseudomonas aeruginosa with antimicrobial synergy and SAR analysis]]> Rakshit ManhasArti RathoreUjwal HavelikarShavi MahajanSumit G. GandhiAvisek Mahapa doi:10.1038/s41429-024-00717-3 The Journal of Antibiotics, Published online: 2024-03-21; | doi:10.1038/s41429-024-00717-3 2024-03-21 The Journal of Antibiotics 10.1038/s41429-024-00717-3 https://www.nature.com/articles/s41429-024-00717-3
<![CDATA[Structure of prolylrapamycin: confirmation through a revised and detailed NMR assignment study]]> https://www.nature.com/articles/s41429-024-00714-6 The Journal of Antibiotics, Published online: 19 March 2024; doi:10.1038/s41429-024-00714-6

Structure of prolylrapamycin: confirmation through a revised and detailed NMR assignment study]]>
Annalisa MortoniEugenio CastelliTeresa ReccaPaolo Quadrelli doi:10.1038/s41429-024-00714-6 The Journal of Antibiotics, Published online: 2024-03-19; | doi:10.1038/s41429-024-00714-6 2024-03-19 The Journal of Antibiotics 10.1038/s41429-024-00714-6 https://www.nature.com/articles/s41429-024-00714-6
<![CDATA[Correlation between the spread of IMP-producing bacteria and the promoter strength of <i>bla</i><sub>IMP</sub> genes]]> https://www.nature.com/articles/s41429-024-00715-5 The Journal of Antibiotics, Published online: 15 March 2024; doi:10.1038/s41429-024-00715-5

Correlation between the spread of IMP-producing bacteria and the promoter strength of blaIMP genes]]>
blaIMP genes]]> Yuta KikuchiMariko YoshidaAsaomi KuwaeYukihiro AsamiYuki InahashiAkio Abe doi:10.1038/s41429-024-00715-5 The Journal of Antibiotics, Published online: 2024-03-15; | doi:10.1038/s41429-024-00715-5 2024-03-15 The Journal of Antibiotics 10.1038/s41429-024-00715-5 https://www.nature.com/articles/s41429-024-00715-5